Lysergic Acid Diethylamide: all 35 studies that test it
Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)RecruitingNCT07592689Phase 3
- Shortened LSD Intervention for Major Depressive DisorderNot yet recruitingNCT07503002Phase 1
- Microdosing LSD in Women With Premenstrual DisordersNot yet recruitingNCT07189299Not applicable
- Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy ParticipantsRecruitingNCT06899334Phase 1
- Lysergic Acid Diethylamide (LSD) in Palliative CareRecruitingNCT05883540Phase 2
- The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingEnrolling by invitationNCT05570708Not applicable
- LSD to Improve Cluster Headache Impact TrialRecruitingNCT05477459Phase 2
- LSD Treatment for Persons With Alcohol Use DisorderRecruitingNCT05474989Phase 2
- Lysergic Acid Diethylamide (LSD) as Treatment for Cluster HeadacheRecruitingNCT03781128Phase 2
- A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsCompletedNCT05407064Phase 2Results posted
- Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept TrialCompletedNCT05200936Phase 2Results posted
- Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related AnxietyCompletedNCT00920387Phase 2Results posted
- Drug Effects on Mood and Behavior - ExpectancyCompletedNCT07061886Early Phase 1
- Mood Effects of Serotonin Agonists: DepressionCompletedNCT07017478Early Phase 1
- A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)Active, not recruitingNCT06941844Phase 3
- A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)Active, not recruitingNCT06809595Phase 3
- A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)Active, not recruitingNCT06741228Phase 3
- LSD-Perceptual-Choice-StudyCompletedNCT05976698Not applicable
- Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy SubjectsCompletedNCT05964647Phase 1
- LSD Occupancy of the Serotonin 2A Receptor in the Human BrainActive, not recruitingNCT05953038Early Phase 1
- A Dose-Ranging Study of 50 µg to 100 µg LSD in Healthy VolunteersCompletedNCT05674669Phase 1
- The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship QualityStatus unknownNCT05670184Phase 1/2
- Effects of LSD on Neuroplasticity in Healthy SubjectsCompletedNCT05177419Phase 1
- LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy SubjectsCompletedNCT04865653Phase 1
- Effects of MDMA Co-administration on the Response to LSD in Healthy SubjectsCompletedNCT04516902Phase 1
- A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 YearsCompletedNCT04421105Phase 1
- Comparative Acute Effects of LSD, Psilocybin and MescalineCompletedNCT04227756Phase 1
- LSD Therapy for Persons Suffering From Major DepressionCompletedNCT03866252Phase 2
- Mood Effects of Serotonin AgonistsCompletedNCT03790358Phase 1
- Direct Comparison of Altered States of Consciousness Induced by LSD and PsilocybinCompletedNCT03604744Early Phase 1
- LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety DisordersCompletedNCT03153579Phase 2
- Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion ProcessingCompletedNCT03019822Early Phase 1
- The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy VolunteersCompletedNCT02451072Not applicable
- Neuronal Correlates of Altered States of ConsciousnessCompletedNCT02308969Early Phase 1
- Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled StudyCompletedNCT01878942Early Phase 1